HOME / PUBLICATIONS /

Somatic Kras Mutations and Resistance to EGFR-Targeted Therapies: Is Kras Ready to Include as a Reflex Test With EGFR in NSCLC? An Evidence Synthesis Based Approach

Citation:

Murray S, Siannis F, Bafaloukos D, Kosmidis P, Linardou H. Somatic Kras Mutations and Resistance to EGFR-Targeted Therapies: Is Kras Ready to Include as a Reflex Test With EGFR in NSCLC? An Evidence Synthesis Based Approach. Annals of Oncology. 2012;23:ix85–ix86. Copy at http://www.tinyurl.com/ylsfdebb